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Summary
Objective: Hartley guinea pigs spontaneously develop arthritis that bears morphological, biochemical, and immunohistochemical similarities
to human osteoarthritis. It is characterized by the appearance of superficial fibrillation by 12 months of age and severe cartilage lesions and
eburnation by 18 months of age. This study examines the effect of treatment with a pulsed electromagnetic field (PEMF) upon the
morphological progression of osteoarthritis in this animal model.
Design: Hartley guinea pigs were exposed to a specific PEMF for 1 h/day for 6 months, beginning at 12 months of age. Control animals were
treated identically, but without PEMF exposure. Tibial articular cartilage was examined with histological/histochemical grading of the severity
of arthritis, by immunohistochemistry for cartilage neoepitopes, 3B3(−) and BC-13, reflecting enzymatic cleavage of aggrecan, and by
immunoreactivity to collagenase (MMP-13) and stromelysin (MMP-3). Immunoreactivity to TGFβ, interleukin (IL)-1β, and IL receptor
antagonist protein (IRAP) antibodies was examined to suggest possible mechanisms of PEMF activity.
Results: PEMF treatment preserves the morphology of articular cartilage and retards the development of osteoarthritic lesions. This
observation is supported by a reduction in the cartilage neoepitopes, 3B3(−) and BC-13, and suppression of the matrix-degrading enzymes,
collagenase and stromelysin. Cells immunopositive to IL-1 are decreased in number, while IRAP-positive cells are increased in response to
treatment. PEMF treatment markedly increases the number of cells immunopositive to TGFβ.
Conclusions: Treatment with PEMF appears to be disease-modifying in this model of osteoarthritis. Since TGFβ is believed to upregulate
gene expression for aggrecan, downregulate matrix metalloprotease and IL-1 activity, and upregulate inhibitors of matrix metalloprotease,
the stimulation of TGFβ may be a mechanism through which PEMF favorably affects cartilage homeostasis.
© 2003 Published by Elsevier Science Ltd on behalf of OsteoArthritis Research Society International.
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Introduction
Several new therapeutic strategies have recently been in-
troduced for the treatment of osteoarthritis, including
cyclooxygenase-2 inhibitors, tetracycline derivatives, visco-
supplementation with various preparations of hyaluronic
acid, and oral chondroitin sulfate/glucosamine supple-
ments. While some may provide symptomatic benefit, dis-
ease modification has not been established. Two clinical
trials have been reported, demonstrating symptomatic
benefit with pulsed direct current or low-frequency pulsed
electromagnetic field (PEMF) exposure in human osteo-
arthritis1,2. We have demonstrated that exposure to PEMF
enhances chondrogenic differentiation and the synthesis of
cartilage extracellular matrix proteins3,4. This study explores
the degree to which PEMF treatment may be disease-
modifying in spontaneous osteoarthritis in guinea pigs.
Hartley-strain guinea pigs develop osteoarthritis, begin-
ning at approximately 12 months of age, culminating in
eburnation of the medial tibial plateau by 18 months of
age5,6. The arthritis is characterized by decreases in the
contents of aggrecan and collagen, typical of osteoarthritis,
increases in collagenases, cartilage fibrillation, and subse-
quent degeneration. Sclerotic changes in the subchondral
bone and osteophytes accompany cartilage loss and ebur-
nation. The proteoglycan neoepitope, 3B3(−), is detected in
osteoarthritic cartilage and is a measure of arthritis activ-
ity7. The development of osteoarthritis in this model has
been modified by a number of interventions, including
reduction in body weight and tetracycline derivatives8,9.
PEMF has a number of well-documented physiological
effects, including the upregulation of gene expression for,
and synthesis of, aggrecan and type II collagen3,4. PEMF
has been shown to upregulate members of the TGFβ super
gene family, and this may be an intermediary mechanism of
PEMF activity10–14. TGFβ has important regulatory func-
tions in joints, including the stimulation of aggrecan and
collagen synthesis, the suppression of the pro-enzyme
forms of stromelysin and collagenase, and the suppression
of interleukin (IL)-115,16. The upregulation of TGFβ by
PEMF may be a mechanism of action of PEMF on the
biology of osteoarthritic joints.
Methods
Male 12-month old guinea pigs were allocated randomly
into two groups. Ages were known within 1 month. Treated
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animals were exposed to a 1.5 Hz pulse-burst PEMF (EBI,
Parsippany, NJ) for 1 h/day for 6 months. Control animals
were treated identically, but without exposure to PEMF. All
animals remained in standard guinea pig cage environ-
ments with food and water, ad lib, and vitamin C sup-
plementation. Animals were sacrificed after 6 months, at 18
months of age. Two separate groups of animals were
treated sequentially, representing two replicates of both
control and treated animals. One group consisted of 11
animals (six control and five treated). A replicate experi-
ment was carried out with 13 animals (eight control and five
treated). One control animal and two experimental animals
did not complete the study. Both knees were examined in
each animal. A total of 26 control and 16 treated knees
were available for study.
The PEMF utilized was similar to the one used clinically
for the treatment of fracture repair and is currently
being evaluated for the treatment of clinical symptoms of
Fig. 1. Gross appearance of cartilage lesions stained with India ink. Arrows indicate cartilage lesions. (A) Control, untreated. (B)
PEMF-treated. Lesions from untreated tibial plateaus are approximately 1–5 mm in diameter. When present, lesions in PEMF-treated tibias
were smaller and superficial.
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osteoarthritis (EBI). The applied magnetic field consisted of
a pulse burst of 30 ms duration, repeated at 1.5 bursts per
second with a peak magnetic field of 1.0 G. Fourier analy-
sis of this signal has indicated significant energy content in
the low-frequency range, below 75 Hz. Dose response
studies in our laboratory with this signal at 1, 4, and 8 h/day
of exposure have demonstrated a maximal stimulatory
effect on chondrogenesis at 1 h/day (reference 17 and
unpublished data). It has been suggested that sham-
exposed controls using counterwound coils with the identi-
cal electric field be utilized in addition to non-exposed
controls in PEMF studies18. The magnetic field and, there-
fore, the induced electric field in the tissue are thus nulled
out, while any other possible environmental conditions
(e.g., thermal, acoustic, vibrational effects) are not. This is a
useful experimental strategy with signals of simple config-
uration, and one which we have utilized in a study of the
effects of continuous sine waves on chondrogenesis11.
However, with signals of asymmetric shape and rapid
repeat rate, such as the one used in this study, sham
controls are essentially impossible because of the difficulty
in exactly overlaying the signals. If an exact overlay is not
achieved, the time-varying magnetic fields are not nulled,
other field exposures occur, and unknown induced electric
Fig. 2. Histochemical staining of the medial plateau with safranin-O. Examples of control, untreated cartilage (A, mild; B, average; C, severe).
Examples of PEMF-treated cartilage (D, mild; E, average; F, severe). Extensive fibrillation and cleft formation to the calcified zone were
evident in many control tibias. Complete loss of cartilage and exposure of subchondral bone were commonly observed. No specimens in the
PEMF-treated group demonstrated clefts below the transitional zone (4× magnification).
Fig. 3. Histological/histochemical grade. Mean grade of control
tibias was 11.7±0.3 compared with 3.5±0.7 of PEMF-treated
cartilage (P0.0001). These grades reflect preservation of carti-
lage morphology in the PEMF-treated group.
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field variables may be introduced. We have, however,
studied the major potentially confounding environmental
variables on which the suggestion for sham exposure is
based, and have demonstrated no difference between
treated and control environments. Vibration was measured
with an Omega accelerometer at a sensitivity of 0.005 G.
Studies were made using a Fourier spectrum analyzer
comparing active and sham spectra over a frequency range
of 1–5 kHz. No vibration was detected in either active or
sham units. Acoustic measurements were made using
an active pressure zone microphone with a frequency
response from 20 to 18 kHz. No signal was detected in
either active or sham units. Temperature was measured
with a thermistor probe, and <0.1°C variance was detected
between active and sham units.
Both knees from each animal were excised and the tibial
plateau cartilage was marked with India ink to identify
arthritic lesions. The tibias were fixed in Z-fix (Anatech Ltd)
and decalcified with Baxter DeCal solution. The tibias were
embedded in paraffin to create a whole mount of the
proximal tibia, including both medial and lateral plateaus.
Sections (6 µm) were cut in the coronal plane through the
mid-portion of the tibial plateau to produce representative
serial sections. In the case of tibias with lesions in the
medial plateau, the lesions were approximately 1–5 mm in
diameter and occurred in the central one-third of the
plateau. The serial coronal sections included the lesion.
Sections were stained with safranin-O and fast green, and
histological/histochemical (Mankin) grades of the medial
plateau were determined19. In this grading system, 0–6
points are allocated for progressive loss of cartilage struc-
ture, 0–3 points for chondrocyte abnormalities, 0–4 points
for progressive decrease in safranin-O staining, and 0–1
point for loss of tidemark integrity. Sections were scored
without knowledge of their groups, by consensus of two
investigators (RKA and DMcKC). On repeated scoring, the
intra-observer error was 6.8%; the inter-observer error was
8.2%. Comparison of results from the two experiments
demonstrated no significant difference between the
replicate groups, so the results were pooled and were
expressed as mean±S.E.M. Results were compared for
significance by a two-tailed Student’s t-test.
For immunohistochemistry, 6 µm sections were stained
with monoclonal antihuman antibodies conjugated with
peroxidase20,21. Extracellular matrix was examined with
antibodies to the aggrecan neoepitopes, 3B3(−) and BC-
13. The antibody to 3B3 was obtained from ICN (69-621-2)
and was used with and without chondroitinase digestion.
BC-13 was a gift from Dr Bruce Caterson, Cardiff, Wales.
These antibodies recognize aggrecan fragments generated
by enzymatic cleavage and reflect the severity of the
arthritis. Enzyme activity was assessed by immunoreactiv-
ity to stromelysin (MMP-3, Calbiochem) and collagenase
(MMP-13, Chemicon). Cytokines of interest were examined
Fig. 4. Immunohistochemistry of the medial plateau for cartilage neoepitopes reflecting aggrecan cleavage. 3B3(−): (A) control, untreated;
(B) PEMF-treated. BC-13: (A) control, untreated; (B) PEMF-treated. Immunoreactivity in the extracellular matrix is evident in the untreated
controls, but not seen in PEMF-treated cartilage. In addition, there were no immunopositive cells in the PEMF-treated group (10×
magnification).
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with antibodies to IL-1β (Calbiochem), and TGFβ and IL
receptor antagonist protein (IRAP) (both obtained from
R&D Systems). The second antibody for MMP-13 was an
antirabbit IgG (Vectastain Elite ABC kit), and for TGFβ and
IL-1β was antigoat IgG (Biotin, Sigma). The secondary
antibody for all other primary antibodies was a mouse
polyvalent immunoglobulin (IgG, IgA, IgM, or Biotin). Nega-
tive control sections were prepared without primary anti-
body to check for non-specific binding. Immunopositive
cells were counted over a defined area using a microscope
grid and are expressed as cells per unit area.
Results
Gross examination of the tibial plateau sections demon-
strated cartilage lesions on the medial plateau of all control
animals. By contrast, in most specimens, the medial
plateaus from the PEMF-treated group exhibited no gross
lesions, and those lesions that did occur were smaller than
controls (Fig. 1). Histologically, the articular cartilage was
thicker in the PEMF-treated tibias (327±13 µm) compared
with untreated tibias (108±30 µm; P0.0001). The
subchondral bone plate thickness appeared to be greater in
the control group, with several control specimens exhibiting
large subchondral cysts. Cartilage fibrillation and cleft for-
mation to the calcified zone were evident in many untreated
tibias, while no specimens in the treated group showed cleft
formation below the transitional zone (Fig. 2). Complete
loss of cartilage, in arthritic lesions, was common in un-
treated, but was not seen in treated, tibias. Histological/
histochemical grades of PEMF-treated articular cartilage
were significantly lower than controls, reflecting a retar-
dation of the osteoarthritic process (Fig. 3). The mean
histological/histochemical grade in the control group was
11.7±0.3 compared with 3.5±0.7 in the PEMF-treated
group (P0.0001). Preservation of cartilage matrix by
PEMF treatment, observed histochemically, was supported
by immunoreactivity to 3B3(−) and BC-13 in the extracellu-
lar matrix of the medial plateau cartilage (Fig. 4). Matrix
immunoreactivity to these antibodies was decreased by
PEMF treatment, suggesting decreased enzymatic cleav-
age of aggrecan, consistent with matrix preservation.
Immunopositive cells to the various antibodies were
observed primarily in the superficial zones of the ar-
ticular cartilage. Because this tissue was lost in the
arthritic lesions of the medial tibial plateau, quantitation of
Fig. 5. Immunohistochemistry of the lateral plateau for the matrix-degrading enzymes, stromelysin (MMP-3), and collagenase (MMP-13).
MMP-3: (A) control, untreated; (B) PEMF-treated. MMP-13: (C) control, untreated; (D) PEMF-treated. Fewer immunopositive cells were
observed in the PEMF-treated specimens (10× magnification). Quantitated data are presented in Table I.
Table I
Immunopositive cells (per unit area)
Control PEMF-
treated
%
Change
P
Collagenase type II 7.2±0.8 0.0±0.0 – 0.01
Stromelysin 13.8±1.9 8.4±1.0 −39 0.02
IL-1β 13.9±2.3 7.2±0.6 −48 0.01
IRAP 10.5±1.0 17.3±1.1 +65 0.003
TGFβ 20.0±3.5 34.4±2.8 +72 0.006
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immunopositive cells was performed in the corresponding
lateral plateau for each of the treated and untreated tibias.
Cartilage from PEMF-treated tibial plateaus demonstrated
significant reductions in the number of cells immunoreac-
tive to antibodies for collagenase (MMP-13) and strome-
lysin (MMP-3) (Fig. 5). The number of cells immunopositive
to stromelysin was decreased by 39% by PEMF treatment
(Table I). PEMF treatment reduced the number of cells
immunopositive for IL-1 and increased the number of cells
immunopositive for IRAP and TGFβ (Fig. 6). The number of
cells positive to IL-1 was reduced by 48%, while immuno-
reactivity to IRAP was increased by 65% by PEMF treat-
ment. The number of TGFβ-positive cells was increased by
72% in EMF-treated, compared with control, tibias (Table I).
Discussion
Osteoarthritis in the Hartley-strain guinea pigs
resembles the morphologic characteristics seen in human
Fig. 6. Immunohistochemistry of the lateral plateau for cytokines. IL-1: (A) control, untreated; (B) PEMF-treated. IRAP: (C) control, untreated;
(D) PEMF-treated. TGFβ: (E) control, untreated; (F) PEMF-treated. A reduction in the number of cells immunoreactive to IL-1 and an increase
in the number of cells immunoreactive to IRAP and TGFβ were observed in PEMF-treated cartilage (10× magnification). Quantitated data are
presented in Table I.
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osteoarthritis. Radiographic features include sclerosis of
the subchondral bone plate and osteophytes22. Biochemi-
cal characteristics include loss of aggrecan and type II
collagen and a transient increase in cartilage water
content23. Collagenases are elevated in the arthritic carti-
lage24,25. Aggrecan neoepitopes appear and reflect the
severity of the arthritis7. A preliminary examination of
animals at 8, 12, and 18 months of age in our laboratory
confirmed uniform progression, as reported by other
laboratories, culminating in severe osteoarthritic
changes, including eburnation, subchondral sclerosis,
and occasional osteophytes at 18 months of age.
The data reported in this study demonstrate a reduction
in the severity of osteoarthritis and preservation of articular
cartilage by exposure to a particular PEMF. This was
manifested by significantly lower histological/histochemical
grades, reflecting less cartilage destruction in PEMF-
treated knees. The preservation of the extracellular matrix
was further demonstrated by a reduction in the neo-
epitopes, 3B3(−) and BC-13. The reduction of immuno-
reactivity to these antibodies by PEMF treatment indicates
less severe enzymatic damage to aggrecan. The number of
cells immunopositive to antibodies against collagenase
(MMP-13) and stromelysin (MMP-3) was markedly reduced
as well, indicating that two of the major cartilage-degrading
enzymes were suppressed by PEMF treatment.
The number of cells immunoreactive to TGFβ, IL-β, and
IRAP was determined to suggest possible mechanisms of
PEMF activity. IL-1 is known to increase the production of
MMPs and inhibits the synthesis of aggrecan and type II
collagen. IL-1 is present in the synovial fluid and cartilage
matrix of osteoarthritic joints. Antagonists of IL-1, including
IRAP and TGFβ, are capable of ameliorating some of the
IL-1-mediated effects on cartilage matrix degradation26–28.
IL-1 immunoreactivity was reduced by 48%, while IRAP
was increased by 65% by PEMF exposure. TGFβ was
increased by 72%. The upregulation of TGFβ has assumed
a central position in the hypothesized mechanism of action
of PEMF. In other studies in our laboratory, PEMFs have
been shown to upregulate TGFβ expression during chon-
drogenesis4,11,14. Depending on the type of PEMF utilized,
mRNA for TGFβ was increased by 68–158%; TGFβ protein
was increased by 21–25%, coincident with 119–343%
increases in the number of cells immunopositive for TGFβ.
These observations have been confirmed in MG63 and
human fracture non-union cells12,13. In these studies, TGFβ
has been shown to be elevated, and PGE-2 to be
suppressed, by PEMF treatment. Upregulation of TGFβ
has also been demonstrated in vitro by direct electrical
stimulation of MC3T3 cells29.
TGFβ has been shown to have several important regu-
latory activities in synovium and articular cartilage. These
include: (1) upregulation of gene expression for aggrecan;
(2) downregulation of pro-stromelysin and pro-collagenase;
(3) upregulation of tissue inhibitors of metalloprotease
(TIMP); and (4.) suppression of IL-1 activity. TGFβ has
been shown to inhibit IL-1-induced protease activity and
subsequent aggrecan degradation15,27,28. Treatment with
TGFβ blocks IL-1-mediated reduction in aggrecan depo-
sition in the extracellular matrix. These studies have indi-
cated that TGFβ can inhibit the IL-1-mediated catabolic
effects on chondrocytes. Together with the upregulation of
aggrecan expression, these observations suggest that
TGFβ regulates cartilage homeostasis and may result in
maintenance of extracellular matrix morphology.
High doses of TGFβ have been shown to have adverse
effects in the murine knee27. TGFβ injection (100 ng) into
joints not only increases proteoglycan synthesis in articular
cartilage, but also produces inflammation and synovial
hyperplasia. Within 2 weeks after three intra-articular injec-
tions, osteophyte formation has been observed. Two
months after a series of three injections of TGFβ (200 ng),
severe proteoglycan depletion and loss of articular carti-
lage to the tidemark were observed. We have not observed
an increase in osteophyte formation in knees treated with
PEMF, even though TGFβ is upregulated. Other studies in
our laboratory have demonstrated that sustained increases
in TGFβ can be produced above constitutive levels by
PEMF of 11 pg/mg tissue, or 0.08 pg/µg DNA14. PEMF
stimulates sustained moderate increases in TGFβ, suf-
ficient to favorably alter the homeostatic balance of
cartilage matrix degradation and synthesis in favor of
preservation of cartilage morphology without the induction
of local toxicity. The stimulation of TGFβ together with
considerations of its regulatory role in joints supports the
hypothesis that upregulation of TGFβ expression may
be an intermediate mechanism of PEMF modification of
osteoarthritis.
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